Search Results

You are looking at 1 - 10 of 21 items for :

  • diabetic retinopathy x
Clear All
Open access

Eva O Melin, Jonatan Dereke, Maria Thunander and Magnus Hillman

Introduction Diabetic retinopathy (DR) is the most common complication of diabetes ( 1 , 2 ) and is a major cause of blindness ( 3 , 4 ). DR progresses over time, but fortunately only a limited number of patients acquire one of the two major

Open access

E R Polina, F M Oliveira, R C Sbruzzi, D Crispim, L H Canani and K G Santos

Introduction Diabetic retinopathy (DR) is a neurodegenerative complication of diabetes ( 1 ) consistently associated with other diabetic complications and with an overall worse prognosis ( 2 ). Hyperglycaemia triggers the activation of

Open access

W Liu, Y Wang, X Han, X Cai, Y Zhu, M Zhang, S Gong, J Li and L Ji

are the conventionally used predictors of diabetic retinopathy (DR) and diabetic nephropathy (DN). ( 2 , 3 ) Previous studies have shown that almost all T1DM patients are likely to develop some degree of DN within 20 years of diagnosis. ( 4 , 5 ) In

Open access

Louise Færch, Anders Juul, Ulrik Pedersen-Bjergaard and Birger Thorsteinsson

Sandler L Joplin GF Kohner EM . Long-term follow-up of patients who underwent yttrium-90 pituitary implantation for treatment of proliferative diabetic retinopathy . Diabetologia 1987 30 199 – 207 . ( doi:10.1007/BF00270416 ). 3 Luft R

Open access

Xiaolei Hu and Fengling Chen

be associated with IAs ( 1 ). Moreover, the majority of human studies have shown no relationship between IAs and diabetic microangiopathic complications, including nephropathy, retinopathy and neuropathy ( 1 ). Treatments for EIAS

Open access

Xiangyu Gao, Wanwan Sun, Yi Wang, Yawen Zhang, Rumei Li, Jinya Huang and Yehong Yang

conditions including diabetic retinopathy, diabetic nephropathy, and diabetic neuropathy, nonalcoholic fatty liver disease (NAFLD) and cardiovascular disease ( 1 ). The incidence of diabetes is on worrisome rise globally, especially in China ( 2

Open access

A H Ludwig-Slomczynska, S Borys, M T Seweryn, J Hohendorff, P Kapusta, B Kiec-Wilk, E Pitera, P P Wolkow and M T Malecki

activation, which might lead to vascular events, neuropathy, retinopathy and DFS ( 30 , 31 , 32 ), the NPWT therapy might have a more pronounced effect in diabetic patients and differently influence the cellular composition of the wound. Moreover, the only

Open access

Taís S Assmann, Mariana Recamonde-Mendoza, Bianca M De Souza and Daisy Crispim

5 19 6.5 Yousefzadeh et al . 2015 ( 55 ) Iran Male Sprague-Dawley rats induced with STZ Sciatic nerve 6/6 RT-PCR 0.05 1 1 0 6.0 DR, diabetic retinopathy; EPC, Endothelial Progenitor cells; N/A, not available

Open access

M Boering, P R van Dijk, S J J Logtenberg, K H Groenier, B H R Wolffenbuttel, R O B Gans, N Kleefstra and H J G Bilo

2 (10) 1 (10) 1 (10) Microvascular complications 9 (45) 5 (50) 4 (40)  Neuropathy 6 (30) 3 (30) 3 (30)  Nephropathy 1 (5) 0 (0.0) 1 (10)  Retinopathy 6 (30) 2 (20) 4 (40) Total daily insulin

Open access

Taísa A R Vicente, Ívina E S Rocha, Roberto Salvatori, Carla R P Oliveira, Rossana M C Pereira, Anita H O Souza, Viviane C Campos, Elenilde G Santos, Rachel D C Araújo Diniz, Eugênia H O Valença, Carlos C Epitácio-Pereira, Mario C P Oliveira, Andrea Mari and Manuel H Aguiar-Oliveira

. Diabetic retinopathy in two patients with congenital IGFI deficiency (Laron syndrome) . European Journal of Endocrinology 2004 151 103 – 106 . ( doi:10.1530/eje.0.1510103 ). 21 Laron Z Weinberger D . Diabetic retinopathy, nephropathy and